 Travis Nemkov
Concepts (605)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 50 | 2025 | 673 | 7.570 |
Why?
| | Blood Preservation | 27 | 2025 | 271 | 3.770 |
Why?
| | Metabolomics | 32 | 2025 | 652 | 3.420 |
Why?
| | Metabolome | 23 | 2023 | 338 | 2.730 |
Why?
| | Hemolysis | 10 | 2025 | 199 | 2.550 |
Why?
| | Blood Donors | 9 | 2025 | 96 | 2.260 |
Why?
| | Glycolysis | 21 | 2025 | 311 | 2.210 |
Why?
| | Erythrocyte Transfusion | 12 | 2025 | 181 | 1.450 |
Why?
| | Mass Spectrometry | 11 | 2019 | 713 | 1.350 |
Why?
| | High-Throughput Screening Assays | 4 | 2021 | 138 | 1.330 |
Why?
| | Drosophila Proteins | 8 | 2025 | 185 | 1.220 |
Why?
| | Drosophila melanogaster | 9 | 2025 | 210 | 1.210 |
Why?
| | Carnitine | 4 | 2024 | 76 | 1.130 |
Why?
| | Hypoxia | 11 | 2024 | 1084 | 1.090 |
Why?
| | Energy Metabolism | 11 | 2024 | 873 | 1.030 |
Why?
| | Amino Acids | 10 | 2023 | 486 | 0.990 |
Why?
| | Oxidative Stress | 14 | 2025 | 1266 | 0.970 |
Why?
| | Animals | 71 | 2025 | 35309 | 0.870 |
Why?
| | Membrane Lipids | 2 | 2021 | 91 | 0.840 |
Why?
| | Proteomics | 8 | 2025 | 1054 | 0.830 |
Why?
| | Shock, Hemorrhagic | 7 | 2020 | 165 | 0.820 |
Why?
| | Mice | 40 | 2025 | 16915 | 0.790 |
Why?
| | Erythroblasts | 1 | 2022 | 15 | 0.790 |
Why?
| | Athletic Performance | 1 | 2023 | 77 | 0.760 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 4 | 2025 | 30 | 0.750 |
Why?
| | Lipid Metabolism | 6 | 2021 | 497 | 0.730 |
Why?
| | Purines | 4 | 2022 | 172 | 0.720 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 66 | 0.680 |
Why?
| | Physical Exertion | 1 | 2021 | 205 | 0.650 |
Why?
| | Hemoglobins | 5 | 2024 | 339 | 0.650 |
Why?
| | Leukemia | 2 | 2019 | 229 | 0.650 |
Why?
| | Prescription Drugs | 1 | 2021 | 112 | 0.640 |
Why?
| | Fatty Acids | 7 | 2024 | 427 | 0.630 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2025 | 274 | 0.620 |
Why?
| | Iron | 3 | 2025 | 281 | 0.620 |
Why?
| | Humans | 100 | 2025 | 129266 | 0.610 |
Why?
| | Carbon | 2 | 2017 | 204 | 0.600 |
Why?
| | Lymph | 2 | 2016 | 32 | 0.600 |
Why?
| | Blood Platelets | 4 | 2025 | 380 | 0.590 |
Why?
| | Cell Death | 1 | 2020 | 354 | 0.590 |
Why?
| | Leukemia, Myeloid, Acute | 7 | 2020 | 592 | 0.580 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.570 |
Why?
| | Muscle, Skeletal | 9 | 2025 | 1613 | 0.570 |
Why?
| | Anemia | 3 | 2024 | 160 | 0.560 |
Why?
| | Aging | 8 | 2024 | 1774 | 0.550 |
Why?
| | Bone Marrow | 1 | 2018 | 271 | 0.540 |
Why?
| | Altitude Sickness | 5 | 2018 | 141 | 0.510 |
Why?
| | Nitrogen | 1 | 2017 | 162 | 0.500 |
Why?
| | Exercise Tolerance | 3 | 2025 | 273 | 0.500 |
Why?
| | Transfusion Medicine | 1 | 2015 | 12 | 0.500 |
Why?
| | Biomarkers | 10 | 2024 | 3968 | 0.480 |
Why?
| | Oxidation-Reduction | 10 | 2022 | 1028 | 0.480 |
Why?
| | Inflammation | 7 | 2024 | 2737 | 0.480 |
Why?
| | Kynurenine | 5 | 2024 | 114 | 0.470 |
Why?
| | Exercise | 3 | 2023 | 1925 | 0.470 |
Why?
| | Lipids | 1 | 2019 | 625 | 0.470 |
Why?
| | Hematopoietic Stem Cells | 3 | 2024 | 381 | 0.470 |
Why?
| | Male | 51 | 2025 | 63512 | 0.460 |
Why?
| | Receptor, Adenosine A2B | 3 | 2021 | 43 | 0.440 |
Why?
| | Mice, Inbred C57BL | 16 | 2025 | 5439 | 0.430 |
Why?
| | Glucosephosphate Dehydrogenase | 3 | 2025 | 56 | 0.410 |
Why?
| | Taste Buds | 1 | 2015 | 204 | 0.400 |
Why?
| | Hemorrhage | 2 | 2022 | 678 | 0.390 |
Why?
| | Neoplastic Stem Cells | 4 | 2021 | 379 | 0.380 |
Why?
| | Healthy Volunteers | 7 | 2021 | 200 | 0.380 |
Why?
| | Mitochondria | 6 | 2025 | 877 | 0.370 |
Why?
| | Female | 47 | 2025 | 68551 | 0.370 |
Why?
| | Oxygen | 5 | 2020 | 915 | 0.370 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2019 | 580 | 0.360 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2021 | 756 | 0.340 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 513 | 0.340 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2020 | 215 | 0.330 |
Why?
| | Flavones | 2 | 2019 | 10 | 0.330 |
Why?
| | Adult | 27 | 2025 | 35495 | 0.320 |
Why?
| | Sphingosine | 3 | 2023 | 40 | 0.320 |
Why?
| | Myelodysplastic Syndromes | 2 | 2023 | 129 | 0.320 |
Why?
| | Rats, Sprague-Dawley | 8 | 2020 | 2396 | 0.320 |
Why?
| | Altitude | 4 | 2023 | 462 | 0.310 |
Why?
| | Blood Banks | 3 | 2019 | 40 | 0.310 |
Why?
| | Lysophospholipids | 3 | 2023 | 72 | 0.310 |
Why?
| | Adenine | 2 | 2025 | 256 | 0.310 |
Why?
| | Blood Transfusion | 4 | 2024 | 295 | 0.290 |
Why?
| | Neoplasm Proteins | 2 | 2025 | 422 | 0.290 |
Why?
| | Polyamines | 3 | 2024 | 39 | 0.290 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 387 | 0.280 |
Why?
| | Thrombosis | 2 | 2022 | 343 | 0.280 |
Why?
| | Acclimatization | 3 | 2018 | 165 | 0.280 |
Why?
| | Wounds and Injuries | 3 | 2020 | 711 | 0.270 |
Why?
| | Hematopoiesis | 2 | 2018 | 183 | 0.270 |
Why?
| | Proteome | 4 | 2020 | 438 | 0.270 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2017 | 46 | 0.270 |
Why?
| | Arginine | 3 | 2024 | 265 | 0.260 |
Why?
| | Mammals | 3 | 2023 | 272 | 0.260 |
Why?
| | Erythrocyte Aging | 2 | 2024 | 13 | 0.260 |
Why?
| | Sciuridae | 2 | 2019 | 146 | 0.260 |
Why?
| | Gene Expression Regulation, Leukemic | 2 | 2016 | 50 | 0.260 |
Why?
| | Plasma | 3 | 2017 | 205 | 0.260 |
Why?
| | Oxygen Consumption | 4 | 2024 | 672 | 0.260 |
Why?
| | Isotope Labeling | 2 | 2017 | 74 | 0.250 |
Why?
| | Tryptophan | 4 | 2021 | 178 | 0.250 |
Why?
| | Insulin Resistance | 3 | 2021 | 1165 | 0.250 |
Why?
| | Drosophila | 2 | 2024 | 140 | 0.250 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 480 | 0.250 |
Why?
| | Collagen | 2 | 2020 | 433 | 0.250 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 169 | 0.250 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 339 | 0.250 |
Why?
| | Erythropoiesis | 2 | 2023 | 51 | 0.240 |
Why?
| | Coronavirus Infections | 2 | 2020 | 333 | 0.240 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 2025 | 5 | 0.240 |
Why?
| | Rats | 7 | 2021 | 5482 | 0.240 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2025 | 119 | 0.240 |
Why?
| | Pentose Phosphate Pathway | 4 | 2018 | 50 | 0.240 |
Why?
| | Interleukin-1 | 2 | 2021 | 959 | 0.240 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.230 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 495 | 0.230 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 85 | 0.230 |
Why?
| | Polymorphism, Genetic | 2 | 2025 | 639 | 0.230 |
Why?
| | Phosphofructokinases | 1 | 2024 | 7 | 0.230 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2024 | 9 | 0.230 |
Why?
| | Hexokinase | 1 | 2024 | 18 | 0.230 |
Why?
| | Rejuvenation | 1 | 2024 | 18 | 0.230 |
Why?
| | Cell Line, Tumor | 10 | 2023 | 3202 | 0.230 |
Why?
| | Physical Conditioning, Animal | 2 | 2025 | 229 | 0.230 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 49 | 0.220 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2018 | 197 | 0.220 |
Why?
| | Adenosine Triphosphate | 2 | 2024 | 478 | 0.220 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.220 |
Why?
| | Mitochondria, Muscle | 3 | 2021 | 111 | 0.220 |
Why?
| | Mice, Knockout | 5 | 2025 | 2871 | 0.220 |
Why?
| | Emtricitabine | 1 | 2025 | 168 | 0.220 |
Why?
| | Blood Group Antigens | 1 | 2023 | 15 | 0.220 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 11 | 0.220 |
Why?
| | Erythrocyte Deformability | 2 | 2021 | 15 | 0.220 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 26 | 0.220 |
Why?
| | Middle Aged | 14 | 2025 | 31090 | 0.220 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1085 | 0.220 |
Why?
| | Glutamine | 3 | 2019 | 99 | 0.220 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 201 | 0.210 |
Why?
| | Uric Acid | 1 | 2025 | 161 | 0.210 |
Why?
| | Chromatography, Liquid | 3 | 2025 | 424 | 0.210 |
Why?
| | Cerebral Hemorrhage | 1 | 2024 | 105 | 0.210 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2023 | 29 | 0.210 |
Why?
| | Tenofovir | 1 | 2025 | 231 | 0.210 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 42 | 0.210 |
Why?
| | Isoenzymes | 1 | 2024 | 302 | 0.210 |
Why?
| | Succinates | 1 | 2023 | 23 | 0.210 |
Why?
| | Larva | 5 | 2025 | 214 | 0.210 |
Why?
| | Oxidative Phosphorylation | 3 | 2018 | 187 | 0.210 |
Why?
| | Lactates | 1 | 2023 | 85 | 0.210 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 159 | 0.210 |
Why?
| | Furin | 1 | 2022 | 13 | 0.210 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 204 | 0.210 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 77 | 0.200 |
Why?
| | 2,3-Diphosphoglycerate | 5 | 2023 | 32 | 0.200 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 248 | 0.200 |
Why?
| | Equidae | 1 | 2022 | 4 | 0.200 |
Why?
| | Obesity | 5 | 2021 | 2879 | 0.200 |
Why?
| | src-Family Kinases | 1 | 2023 | 95 | 0.200 |
Why?
| | Histiocytosis | 1 | 2022 | 7 | 0.200 |
Why?
| | Liver | 3 | 2019 | 1839 | 0.190 |
Why?
| | Glucose | 3 | 2017 | 1001 | 0.190 |
Why?
| | Bicycling | 1 | 2023 | 116 | 0.190 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2022 | 191 | 0.190 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 107 | 0.190 |
Why?
| | Erdheim-Chester Disease | 1 | 2021 | 5 | 0.190 |
Why?
| | Neutrophils | 2 | 2025 | 1207 | 0.190 |
Why?
| | Sulfonamides | 3 | 2020 | 495 | 0.190 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 224 | 0.180 |
Why?
| | Aged | 8 | 2024 | 22032 | 0.180 |
Why?
| | Transgender Persons | 1 | 2024 | 172 | 0.180 |
Why?
| | Protein Domains | 1 | 2022 | 253 | 0.180 |
Why?
| | Cholesterol | 2 | 2022 | 412 | 0.180 |
Why?
| | Sphingolipids | 2 | 2021 | 71 | 0.180 |
Why?
| | Asparagine | 2 | 2018 | 30 | 0.180 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.180 |
Why?
| | Erythrocyte Count | 1 | 2021 | 19 | 0.180 |
Why?
| | Testosterone | 1 | 2024 | 372 | 0.180 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 186 | 0.180 |
Why?
| | Lactic Acid | 5 | 2024 | 298 | 0.180 |
Why?
| | Auditory Pathways | 1 | 2021 | 55 | 0.180 |
Why?
| | Syndecan-1 | 1 | 2020 | 27 | 0.180 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 65 | 0.180 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 32 | 0.180 |
Why?
| | Virulence Factors | 1 | 2022 | 156 | 0.180 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 178 | 0.180 |
Why?
| | Metformin | 1 | 2024 | 315 | 0.180 |
Why?
| | Resistance Training | 1 | 2023 | 151 | 0.180 |
Why?
| | Cell Plasticity | 1 | 2021 | 27 | 0.180 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 259 | 0.180 |
Why?
| | Extracellular Vesicles | 1 | 2022 | 129 | 0.170 |
Why?
| | Benzothiazoles | 2 | 2017 | 32 | 0.170 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1327 | 0.170 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 86 | 0.170 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 81 | 0.170 |
Why?
| | Stromal Cells | 1 | 2020 | 105 | 0.170 |
Why?
| | Cannabidiol | 1 | 2022 | 108 | 0.170 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 118 | 0.170 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 95 | 0.170 |
Why?
| | Time Factors | 10 | 2024 | 6543 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 3 | 2025 | 523 | 0.170 |
Why?
| | Cannabinoids | 1 | 2022 | 153 | 0.170 |
Why?
| | Osmotic Pressure | 1 | 2020 | 35 | 0.170 |
Why?
| | Phenylurea Compounds | 2 | 2017 | 89 | 0.170 |
Why?
| | TCF Transcription Factors | 1 | 2019 | 16 | 0.170 |
Why?
| | Macrophage Activation | 1 | 2021 | 189 | 0.170 |
Why?
| | Macrophages | 4 | 2022 | 1484 | 0.170 |
Why?
| | Taurine | 1 | 2020 | 43 | 0.170 |
Why?
| | Transcription Factors | 2 | 2025 | 1647 | 0.160 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2019 | 24 | 0.160 |
Why?
| | Phosphatidylserines | 1 | 2020 | 88 | 0.160 |
Why?
| | Shock | 1 | 2020 | 92 | 0.160 |
Why?
| | Hibernation | 2 | 2019 | 74 | 0.160 |
Why?
| | Signal Transduction | 8 | 2025 | 4926 | 0.160 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2021 | 209 | 0.160 |
Why?
| | Parabiosis | 1 | 2019 | 11 | 0.160 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 194 | 0.160 |
Why?
| | Hydrogen Peroxide | 1 | 2021 | 318 | 0.160 |
Why?
| | Tryptophan Oxygenase | 2 | 2018 | 35 | 0.160 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 310 | 0.160 |
Why?
| | Machine Learning | 2 | 2021 | 442 | 0.160 |
Why?
| | Circadian Clocks | 1 | 2019 | 45 | 0.160 |
Why?
| | Torpor | 1 | 2019 | 14 | 0.160 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 857 | 0.160 |
Why?
| | Anemia, Sickle Cell | 2 | 2024 | 252 | 0.150 |
Why?
| | Homeostasis | 2 | 2022 | 605 | 0.150 |
Why?
| | Cigarette Smoking | 1 | 2020 | 91 | 0.150 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 454 | 0.150 |
Why?
| | Anti-HIV Agents | 1 | 2025 | 754 | 0.150 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2024 | 541 | 0.150 |
Why?
| | Aspartic Acid | 1 | 2018 | 80 | 0.150 |
Why?
| | Gene-Environment Interaction | 1 | 2020 | 185 | 0.150 |
Why?
| | Blood Specimen Collection | 1 | 2018 | 35 | 0.150 |
Why?
| | Renal Insufficiency | 1 | 2020 | 149 | 0.150 |
Why?
| | Transcriptome | 2 | 2021 | 874 | 0.150 |
Why?
| | Adenosine | 2 | 2017 | 227 | 0.150 |
Why?
| | Hypertension, Pulmonary | 2 | 2021 | 1894 | 0.150 |
Why?
| | Arousal | 1 | 2019 | 149 | 0.150 |
Why?
| | Stem Cell Niche | 1 | 2018 | 53 | 0.150 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4057 | 0.150 |
Why?
| | Deamination | 1 | 2017 | 5 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 195 | 0.140 |
Why?
| | Proteostasis | 1 | 2018 | 27 | 0.140 |
Why?
| | Cryopreservation | 1 | 2018 | 92 | 0.140 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 11 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2020 | 240 | 0.140 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 18 | 0.140 |
Why?
| | Hemoglobin A | 1 | 2017 | 22 | 0.140 |
Why?
| | Benzeneacetamides | 1 | 2017 | 7 | 0.140 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 389 | 0.140 |
Why?
| | Diglycerides | 1 | 2018 | 61 | 0.140 |
Why?
| | Glutaminase | 1 | 2017 | 10 | 0.140 |
Why?
| | Resuscitation | 2 | 2018 | 236 | 0.140 |
Why?
| | Nicotine | 1 | 2020 | 302 | 0.140 |
Why?
| | Thiadiazoles | 1 | 2017 | 24 | 0.140 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 631 | 0.140 |
Why?
| | Calcium | 2 | 2022 | 1212 | 0.140 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 48 | 0.140 |
Why?
| | Immune System | 1 | 2018 | 175 | 0.140 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 17 | 0.140 |
Why?
| | Young Adult | 8 | 2021 | 12391 | 0.140 |
Why?
| | Limit of Detection | 1 | 2017 | 82 | 0.140 |
Why?
| | Body Fluids | 1 | 2017 | 63 | 0.140 |
Why?
| | Nitriles | 1 | 2018 | 172 | 0.140 |
Why?
| | Neoplasms | 2 | 2022 | 2449 | 0.130 |
Why?
| | Basigin | 1 | 2017 | 25 | 0.130 |
Why?
| | Citric Acid | 1 | 2016 | 30 | 0.130 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 149 | 0.130 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.130 |
Why?
| | Breast Neoplasms | 2 | 2020 | 2140 | 0.130 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2063 | 0.130 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 66 | 0.130 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 40 | 0.130 |
Why?
| | Inflammasomes | 1 | 2018 | 126 | 0.130 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2025 | 820 | 0.130 |
Why?
| | Interleukin-6 | 1 | 2020 | 720 | 0.130 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 346 | 0.130 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 327 | 0.130 |
Why?
| | Folic Acid | 1 | 2017 | 184 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2018 | 272 | 0.130 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 117 | 0.130 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 341 | 0.130 |
Why?
| | Brain Death | 1 | 2016 | 46 | 0.130 |
Why?
| | Models, Biological | 2 | 2021 | 1722 | 0.130 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2016 | 79 | 0.130 |
Why?
| | Phosphatidylethanolamines | 1 | 2016 | 74 | 0.130 |
Why?
| | Diethylhexyl Phthalate | 1 | 2015 | 15 | 0.120 |
Why?
| | Bacteria | 1 | 2022 | 813 | 0.120 |
Why?
| | Antioxidants | 1 | 2019 | 558 | 0.120 |
Why?
| | Reactive Oxygen Species | 4 | 2022 | 596 | 0.120 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 149 | 0.120 |
Why?
| | Metabolic Flux Analysis | 1 | 2015 | 7 | 0.120 |
Why?
| | Biochemistry | 1 | 2015 | 38 | 0.120 |
Why?
| | Anoikis | 1 | 2015 | 31 | 0.120 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 566 | 0.120 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.120 |
Why?
| | Acidosis | 1 | 2016 | 89 | 0.120 |
Why?
| | Pandemics | 2 | 2020 | 1481 | 0.120 |
Why?
| | Fluid Therapy | 1 | 2016 | 133 | 0.120 |
Why?
| | Vasodilation | 1 | 2018 | 476 | 0.120 |
Why?
| | Platelet Transfusion | 1 | 2015 | 59 | 0.120 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2015 | 49 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 260 | 0.120 |
Why?
| | Phosphatidylcholines | 1 | 2016 | 145 | 0.120 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 92 | 0.120 |
Why?
| | Immunity, Innate | 1 | 2021 | 803 | 0.120 |
Why?
| | Cell Proliferation | 5 | 2025 | 2375 | 0.120 |
Why?
| | Blood Volume | 1 | 2015 | 60 | 0.120 |
Why?
| | Sulfur | 3 | 2022 | 49 | 0.120 |
Why?
| | Citrates | 1 | 2014 | 42 | 0.120 |
Why?
| | Adipose Tissue | 2 | 2017 | 590 | 0.120 |
Why?
| | Extinction, Biological | 1 | 2015 | 32 | 0.120 |
Why?
| | Amyloid beta-Peptides | 1 | 2017 | 211 | 0.120 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 146 | 0.120 |
Why?
| | Cells, Cultured | 5 | 2021 | 4077 | 0.120 |
Why?
| | Mice, Transgenic | 4 | 2025 | 2117 | 0.120 |
Why?
| | Organ Preservation Solutions | 1 | 2014 | 45 | 0.120 |
Why?
| | Linear Models | 1 | 2017 | 819 | 0.110 |
Why?
| | Health Status | 1 | 2019 | 754 | 0.110 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2017 | 644 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 901 | 0.110 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1202 | 0.110 |
Why?
| | Sodium Chloride | 1 | 2014 | 137 | 0.110 |
Why?
| | Methionine | 3 | 2020 | 156 | 0.110 |
Why?
| | Phosphates | 1 | 2014 | 179 | 0.110 |
Why?
| | Proteolysis | 3 | 2020 | 167 | 0.110 |
Why?
| | Mutation | 5 | 2025 | 3710 | 0.110 |
Why?
| | Fetal Development | 1 | 2016 | 288 | 0.110 |
Why?
| | Peptide Fragments | 1 | 2017 | 692 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 781 | 0.100 |
Why?
| | Antineoplastic Agents | 3 | 2019 | 2054 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 534 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 3773 | 0.100 |
Why?
| | Glucose Tolerance Test | 3 | 2021 | 355 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2439 | 0.100 |
Why?
| | Muscles | 2 | 2023 | 321 | 0.100 |
Why?
| | Nuclear Proteins | 1 | 2017 | 659 | 0.100 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 509 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 752 | 0.100 |
Why?
| | Diet | 1 | 2020 | 1212 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 574 | 0.100 |
Why?
| | MicroRNAs | 1 | 2018 | 676 | 0.090 |
Why?
| | Liver Neoplasms | 1 | 2016 | 640 | 0.090 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 2 | 2025 | 15 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 569 | 0.090 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2019 | 812 | 0.090 |
Why?
| | Microbiota | 1 | 2018 | 728 | 0.090 |
Why?
| | Mice, Inbred NOD | 3 | 2017 | 588 | 0.090 |
Why?
| | HIV Infections | 1 | 2025 | 2719 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 3 | 2023 | 890 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2016 | 1063 | 0.080 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 54 | 0.080 |
Why?
| | Cell Line | 3 | 2022 | 2779 | 0.080 |
Why?
| | Insulin | 2 | 2021 | 2325 | 0.080 |
Why?
| | Bisphosphoglycerate Mutase | 2 | 2021 | 7 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3080 | 0.080 |
Why?
| | Phenotype | 4 | 2020 | 3074 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 881 | 0.080 |
Why?
| | Cattle | 2 | 2022 | 977 | 0.080 |
Why?
| | Glucose Clamp Technique | 2 | 2021 | 194 | 0.080 |
Why?
| | Phosphorylation | 3 | 2018 | 1710 | 0.070 |
Why?
| | Adolescent | 3 | 2024 | 20313 | 0.070 |
Why?
| | Diet, High-Fat | 2 | 2019 | 239 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2020 | 160 | 0.070 |
Why?
| | Macaca | 2 | 2018 | 54 | 0.070 |
Why?
| | Brain | 2 | 2021 | 2669 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 248 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1556 | 0.070 |
Why?
| | Bacterial Proteins | 2 | 2025 | 833 | 0.070 |
Why?
| | Sex Characteristics | 2 | 2023 | 736 | 0.070 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2018 | 196 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2021 | 812 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1344 | 0.070 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 41 | 0.070 |
Why?
| | Neurons | 1 | 2015 | 1494 | 0.070 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 616 | 0.070 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 68 | 0.070 |
Why?
| | Apoptosis | 3 | 2021 | 2499 | 0.060 |
Why?
| | Cell Adhesion | 2 | 2018 | 452 | 0.060 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 390 | 0.060 |
Why?
| | Mice, Nude | 2 | 2018 | 682 | 0.060 |
Why?
| | Isotonic Solutions | 2 | 2016 | 37 | 0.060 |
Why?
| | Biopsy | 2 | 2020 | 1092 | 0.060 |
Why?
| | Swine | 2 | 2018 | 760 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 43 | 0.060 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2025 | 12 | 0.060 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 37 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2025 | 62 | 0.060 |
Why?
| | Glutarates | 1 | 2024 | 8 | 0.060 |
Why?
| | Plateletpheresis | 1 | 2024 | 27 | 0.060 |
Why?
| | Deferoxamine | 1 | 2024 | 20 | 0.060 |
Why?
| | Antimalarials | 1 | 2024 | 30 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 151 | 0.060 |
Why?
| | Cell Survival | 2 | 2019 | 1075 | 0.060 |
Why?
| | Cold Temperature | 2 | 2016 | 154 | 0.060 |
Why?
| | Alanine | 1 | 2025 | 142 | 0.060 |
Why?
| | RNA Interference | 2 | 2017 | 450 | 0.060 |
Why?
| | Organophosphates | 1 | 2025 | 120 | 0.060 |
Why?
| | Indoleacetic Acids | 1 | 2024 | 9 | 0.060 |
Why?
| | Glutathione | 2 | 2016 | 347 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2020 | 746 | 0.060 |
Why?
| | Blood Glucose | 3 | 2020 | 2097 | 0.060 |
Why?
| | Alcohol Oxidoreductases | 1 | 2024 | 60 | 0.060 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.060 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 108 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 877 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 591 | 0.050 |
Why?
| | Respiratory Therapy | 1 | 2023 | 23 | 0.050 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2024 | 85 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 110 | 0.050 |
Why?
| | Prospective Studies | 3 | 2021 | 7123 | 0.050 |
Why?
| | Africa South of the Sahara | 1 | 2023 | 41 | 0.050 |
Why?
| | Puberty | 1 | 2024 | 143 | 0.050 |
Why?
| | Pantothenic Acid | 1 | 2023 | 5 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2024 | 141 | 0.050 |
Why?
| | Dasatinib | 1 | 2023 | 54 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2024 | 181 | 0.050 |
Why?
| | Quantitative Trait Loci | 1 | 2025 | 352 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2023 | 143 | 0.050 |
Why?
| | Hand Strength | 1 | 2023 | 113 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2023 | 52 | 0.050 |
Why?
| | Heme | 1 | 2023 | 77 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2025 | 545 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 70 | 0.050 |
Why?
| | Adipocytes | 1 | 2023 | 204 | 0.050 |
Why?
| | Horses | 1 | 2022 | 107 | 0.050 |
Why?
| | Thrombin | 1 | 2022 | 145 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2022 | 2703 | 0.050 |
Why?
| | Cell Movement | 2 | 2017 | 944 | 0.050 |
Why?
| | Cytokines | 2 | 2022 | 2013 | 0.050 |
Why?
| | Dogs | 1 | 2022 | 382 | 0.050 |
Why?
| | Oncogenes | 1 | 2021 | 112 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2022 | 238 | 0.040 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2020 | 8 | 0.040 |
Why?
| | Subcellular Fractions | 1 | 2021 | 80 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 52 | 0.040 |
Why?
| | Candidiasis | 1 | 2021 | 56 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 110 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5409 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 138 | 0.040 |
Why?
| | Point Mutation | 1 | 2021 | 224 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 97 | 0.040 |
Why?
| | Cystine | 1 | 2020 | 17 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2023 | 332 | 0.040 |
Why?
| | Genome | 1 | 2022 | 277 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 2687 | 0.040 |
Why?
| | Muscle Strength | 1 | 2023 | 303 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 223 | 0.040 |
Why?
| | Fat Body | 1 | 2020 | 4 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 152 | 0.040 |
Why?
| | Creatine | 1 | 2020 | 58 | 0.040 |
Why?
| | Cochlea | 1 | 2021 | 100 | 0.040 |
Why?
| | Niacinamide | 1 | 2020 | 75 | 0.040 |
Why?
| | Phylogeny | 1 | 2023 | 849 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 33 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 4 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2019 | 20 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 43 | 0.040 |
Why?
| | Gene Deletion | 1 | 2021 | 380 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2019 | 206 | 0.040 |
Why?
| | Megakaryocytes | 1 | 2019 | 32 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 7 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 149 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 211 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2020 | 151 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 193 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 27 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 232 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 1965 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 91 | 0.040 |
Why?
| | Drug Design | 1 | 2019 | 156 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1875 | 0.040 |
Why?
| | Succinic Acid | 1 | 2018 | 38 | 0.040 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 91 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 978 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 548 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 192 | 0.040 |
Why?
| | Gluconeogenesis | 1 | 2018 | 76 | 0.040 |
Why?
| | Creatinine | 1 | 2020 | 491 | 0.040 |
Why?
| | Purine Nucleotides | 1 | 2018 | 12 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2024 | 622 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2021 | 505 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 79 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 230 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5050 | 0.040 |
Why?
| | Sarcolemma | 1 | 2018 | 40 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 351 | 0.040 |
Why?
| | Crush Injuries | 1 | 2017 | 9 | 0.040 |
Why?
| | Formic Acid Esters | 1 | 2017 | 4 | 0.040 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2537 | 0.040 |
Why?
| | Prevalence | 1 | 2024 | 2553 | 0.040 |
Why?
| | Metabolism | 1 | 2017 | 38 | 0.040 |
Why?
| | Biological Transport | 1 | 2018 | 404 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 232 | 0.030 |
Why?
| | Azacitidine | 1 | 2018 | 139 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2017 | 81 | 0.030 |
Why?
| | Pyrroles | 1 | 2018 | 202 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1446 | 0.030 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2017 | 38 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 143 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 219 | 0.030 |
Why?
| | Blood Proteins | 1 | 2019 | 244 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 16 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2715 | 0.030 |
Why?
| | Fluorenes | 1 | 2017 | 40 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 346 | 0.030 |
Why?
| | Anaerobiosis | 1 | 2017 | 57 | 0.030 |
Why?
| | Cystathionine | 1 | 2016 | 24 | 0.030 |
Why?
| | Femoral Fractures | 1 | 2017 | 73 | 0.030 |
Why?
| | Periodicity | 1 | 2016 | 57 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1466 | 0.030 |
Why?
| | Weaning | 1 | 2016 | 48 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 941 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 98 | 0.030 |
Why?
| | Nucleotides | 1 | 2017 | 122 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1385 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 98 | 0.030 |
Why?
| | Quality Control | 1 | 2017 | 163 | 0.030 |
Why?
| | NADP | 1 | 2016 | 46 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 23 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 264 | 0.030 |
Why?
| | Hydrazines | 1 | 2016 | 34 | 0.030 |
Why?
| | Hydrogen Sulfide | 1 | 2016 | 42 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 81 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2018 | 237 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2016 | 52 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 220 | 0.030 |
Why?
| | Sesquiterpenes | 1 | 2016 | 53 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 39 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 112 | 0.030 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2016 | 70 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 78 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 148 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 132 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 95 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 527 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 218 | 0.030 |
Why?
| | Body Temperature | 1 | 2016 | 212 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 574 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1090 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 948 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 297 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 641 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 286 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 372 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1288 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 286 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 235 | 0.030 |
Why?
| | Indoles | 1 | 2018 | 384 | 0.030 |
Why?
| | Cysteine | 1 | 2016 | 195 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1487 | 0.030 |
Why?
| | Bison | 1 | 2015 | 6 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2018 | 261 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 142 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2015 | 131 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 187 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 6390 | 0.030 |
Why?
| | Europe | 1 | 2015 | 363 | 0.030 |
Why?
| | Glycosylation | 1 | 2015 | 152 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1497 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2018 | 414 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 250 | 0.030 |
Why?
| | Body Size | 1 | 2015 | 104 | 0.030 |
Why?
| | Sirolimus | 1 | 2016 | 266 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 350 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 479 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1155 | 0.030 |
Why?
| | Biomedical Research | 1 | 2020 | 637 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 915 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2018 | 328 | 0.030 |
Why?
| | Running | 1 | 2017 | 223 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 286 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 347 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1117 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 496 | 0.030 |
Why?
| | Skull | 1 | 2015 | 129 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 991 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 483 | 0.030 |
Why?
| | Postpartum Period | 1 | 2016 | 332 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 612 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1304 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 1040 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2740 | 0.030 |
Why?
| | Up-Regulation | 1 | 2016 | 839 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1269 | 0.030 |
Why?
| | Acute Lung Injury | 1 | 2016 | 279 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1416 | 0.030 |
Why?
| | Body Mass Index | 1 | 2021 | 2272 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 610 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 428 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 3377 | 0.030 |
Why?
| | Athletes | 1 | 2016 | 409 | 0.020 |
Why?
| | Fetus | 1 | 2016 | 770 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 640 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 665 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2056 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 2120 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2835 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 10202 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7055 | 0.020 |
Why?
| | United States | 1 | 2015 | 13826 | 0.010 |
Why?
|
|
Nemkov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|